vs

Side-by-side financial comparison of NATURAL HEALTH TRENDS CORP (NHTC) and Optex Systems Holdings Inc (OPXS). Click either name above to swap in a different company.

NATURAL HEALTH TRENDS CORP is the larger business by last-quarter revenue ($9.7M vs $9.1M, roughly 1.1× Optex Systems Holdings Inc). Optex Systems Holdings Inc runs the higher net margin — 2.6% vs -6.0%, a 8.7% gap on every dollar of revenue. On growth, Optex Systems Holdings Inc posted the faster year-over-year revenue change (11.6% vs -10.1%). Optex Systems Holdings Inc produced more free cash flow last quarter ($-548.0K vs $-964.0K). Over the past eight quarters, Optex Systems Holdings Inc's revenue compounded faster (3.6% CAGR vs -5.6%).

Sword Health is a digital health company that develops physical therapy programs for musculoskeletal (MSK) conditions, pelvic health, and injury prevention. The company was founded in 2015 in Portugal by Virgílio Bento and Márcio Colunas. Its services include digital physical therapy with artificial intelligence (AI) integrated into the care model. As of 2024, Sword Health operates internationally, with offices in the United States, Ireland, and Portugal. The company has been valued at $3 bil...

Optex Systems Holdings Inc. designs, manufactures and supplies high-performance optical, optoelectronic components and integrated subsystems. Its core products include military sighting systems, laser protection solutions and precision optical assemblies, serving defense, aerospace and industrial manufacturing markets globally.

NHTC vs OPXS — Head-to-Head

Bigger by revenue
NHTC
NHTC
1.1× larger
NHTC
$9.7M
$9.1M
OPXS
Growing faster (revenue YoY)
OPXS
OPXS
+21.7% gap
OPXS
11.6%
-10.1%
NHTC
Higher net margin
OPXS
OPXS
8.7% more per $
OPXS
2.6%
-6.0%
NHTC
More free cash flow
OPXS
OPXS
$416.0K more FCF
OPXS
$-548.0K
$-964.0K
NHTC
Faster 2-yr revenue CAGR
OPXS
OPXS
Annualised
OPXS
3.6%
-5.6%
NHTC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NHTC
NHTC
OPXS
OPXS
Revenue
$9.7M
$9.1M
Net Profit
$-588.0K
$242.0K
Gross Margin
72.9%
22.9%
Operating Margin
-6.5%
1.6%
Net Margin
-6.0%
2.6%
Revenue YoY
-10.1%
11.6%
Net Profit YoY
-434.1%
-71.3%
EPS (diluted)
$-0.05
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NHTC
NHTC
OPXS
OPXS
Q4 25
$9.7M
$9.1M
Q3 25
$9.5M
$11.3M
Q2 25
$9.8M
$11.1M
Q1 25
$10.7M
$10.7M
Q4 24
$10.8M
$8.2M
Q3 24
$10.7M
$9.4M
Q2 24
$10.5M
$9.1M
Q1 24
$11.0M
$8.5M
Net Profit
NHTC
NHTC
OPXS
OPXS
Q4 25
$-588.0K
$242.0K
Q3 25
$-431.0K
$1.0M
Q2 25
$15.0K
$1.5M
Q1 25
$122.0K
$1.8M
Q4 24
$176.0K
$844.0K
Q3 24
$35.0K
$1.0M
Q2 24
$173.0K
$1.3M
Q1 24
$188.0K
$1.1M
Gross Margin
NHTC
NHTC
OPXS
OPXS
Q4 25
72.9%
22.9%
Q3 25
73.7%
30.1%
Q2 25
73.9%
28.5%
Q1 25
73.6%
31.3%
Q4 24
74.2%
26.0%
Q3 24
74.1%
25.5%
Q2 24
74.2%
31.8%
Q1 24
73.4%
30.0%
Operating Margin
NHTC
NHTC
OPXS
OPXS
Q4 25
-6.5%
1.6%
Q3 25
-5.2%
18.3%
Q2 25
-3.4%
17.2%
Q1 25
-3.2%
20.8%
Q4 24
-3.9%
11.2%
Q3 24
-2.6%
13.7%
Q2 24
-2.3%
17.8%
Q1 24
-3.3%
15.9%
Net Margin
NHTC
NHTC
OPXS
OPXS
Q4 25
-6.0%
2.6%
Q3 25
-4.5%
9.1%
Q2 25
0.2%
13.6%
Q1 25
1.1%
16.5%
Q4 24
1.6%
10.3%
Q3 24
0.3%
10.7%
Q2 24
1.7%
13.9%
Q1 24
1.7%
12.5%
EPS (diluted)
NHTC
NHTC
OPXS
OPXS
Q4 25
$-0.05
$0.03
Q3 25
$-0.04
$0.14
Q2 25
$0.00
$0.22
Q1 25
$0.01
$0.26
Q4 24
$0.01
$0.12
Q3 24
$0.00
$0.15
Q2 24
$0.02
$0.18
Q1 24
$0.02
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NHTC
NHTC
OPXS
OPXS
Cash + ST InvestmentsLiquidity on hand
$28.9M
$5.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$23.4M
$24.7M
Total Assets
$38.4M
$30.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NHTC
NHTC
OPXS
OPXS
Q4 25
$28.9M
$5.8M
Q3 25
$32.0M
$6.4M
Q2 25
$34.2M
$4.9M
Q1 25
$41.9M
$3.5M
Q4 24
$43.9M
$2.5M
Q3 24
$46.3M
$1.0M
Q2 24
$48.7M
$486.0K
Q1 24
$54.4M
$321.0K
Stockholders' Equity
NHTC
NHTC
OPXS
OPXS
Q4 25
$23.4M
$24.7M
Q3 25
$26.1M
$24.3M
Q2 25
$28.9M
$23.1M
Q1 25
$30.9M
$21.6M
Q4 24
$32.9M
$19.7M
Q3 24
$35.3M
$18.8M
Q2 24
$37.3M
$17.7M
Q1 24
$39.4M
$16.5M
Total Assets
NHTC
NHTC
OPXS
OPXS
Q4 25
$38.4M
$30.2M
Q3 25
$42.3M
$30.1M
Q2 25
$45.2M
$29.2M
Q1 25
$53.2M
$27.5M
Q4 24
$55.4M
$24.8M
Q3 24
$58.3M
$25.5M
Q2 24
$61.5M
$24.9M
Q1 24
$67.6M
$23.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NHTC
NHTC
OPXS
OPXS
Operating Cash FlowLast quarter
$-959.0K
$-92.0K
Free Cash FlowOCF − Capex
$-964.0K
$-548.0K
FCF MarginFCF / Revenue
-9.9%
-6.0%
Capex IntensityCapex / Revenue
0.1%
5.0%
Cash ConversionOCF / Net Profit
-0.38×
TTM Free Cash FlowTrailing 4 quarters
$-6.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NHTC
NHTC
OPXS
OPXS
Q4 25
$-959.0K
$-92.0K
Q3 25
$113.0K
$1.6M
Q2 25
$-5.6M
$1.4M
Q1 25
$484.0K
$1.2M
Q4 24
$88.0K
$2.8M
Q3 24
$-436.0K
$753.0K
Q2 24
$-3.6M
$50.0K
Q1 24
$549.0K
$-1.3M
Free Cash Flow
NHTC
NHTC
OPXS
OPXS
Q4 25
$-964.0K
$-548.0K
Q3 25
$70.0K
$1.5M
Q2 25
$-5.6M
Q1 25
$468.0K
$1.1M
Q4 24
$68.0K
$2.5M
Q3 24
$-443.0K
$545.0K
Q2 24
$-3.6M
$-256.0K
Q1 24
$538.0K
$-1.4M
FCF Margin
NHTC
NHTC
OPXS
OPXS
Q4 25
-9.9%
-6.0%
Q3 25
0.7%
13.5%
Q2 25
-57.5%
Q1 25
4.4%
9.8%
Q4 24
0.6%
30.3%
Q3 24
-4.1%
5.8%
Q2 24
-34.2%
-2.8%
Q1 24
4.9%
-16.3%
Capex Intensity
NHTC
NHTC
OPXS
OPXS
Q4 25
0.1%
5.0%
Q3 25
0.5%
0.4%
Q2 25
0.0%
0.0%
Q1 25
0.1%
1.2%
Q4 24
0.2%
3.9%
Q3 24
0.1%
2.2%
Q2 24
0.2%
3.4%
Q1 24
0.1%
1.3%
Cash Conversion
NHTC
NHTC
OPXS
OPXS
Q4 25
-0.38×
Q3 25
1.52×
Q2 25
-375.67×
0.92×
Q1 25
3.97×
0.67×
Q4 24
0.50×
3.32×
Q3 24
-12.46×
0.74×
Q2 24
-20.62×
0.04×
Q1 24
2.92×
-1.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NHTC
NHTC

Segment breakdown not available.

OPXS
OPXS

Optex Systems OPX Richardson Texas$5.3M58%
Applied Optics Center AOC Dallas$4.0M44%

Related Comparisons